EVP, Global Revenue · DEXCOM INC (DXCM)

Paul Flynn

FY2021 is the first fiscal year CompBrief holds for Paul Flynn as a named executive officer of DEXCOM; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$4,866,159

Salary $373,973Stock awards $4,104,640

4th of 6 named executive officers at Dexcom by FY2021 total.

6 named officers on file for DEXCOM, FY2021

Paul Flynn’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • DXCM’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how DEXCOM’s whole pay program stands against its peers

  • DEXCOM’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on DXCM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 8, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Paul Flynn’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Paul Flynn compensation by year

DEXCOM Summary Compensation Table · the one fiscal year held
In US dollars, as DEXCOM reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$373,973
Bonus$0
Stock awards$4,104,640
Option awards$0
Non-equity incentive$367,428
Pension and deferred compensation$0
All other$20,118
Total$4,866,159

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DEXCOM INC DEF 14A filed April 8, 2022, accession 0001093557-22-000085, and prior-year filings. Open the filing on EDGAR.

How this page was built: the DEXCOM INC filed document, accession 0001093557-22-000085. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,634$3,025,176—
RSU3,916$2,102,696—
RSU2,925$1,570,579—
PSU2,818$1,513,125—
RSU1,378$739,917—

Per the Outstanding Equity Awards at Fiscal Year-End table in DEXCOM INC's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2021 proxy (filed April 8, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-12-18Disposition to the issuer—3,163$121.8548,949
2023-04-17Sale—2,781$120.0052,112
2023-03-13Sale—2,782$106.2754,893
2023-03-10Disposition to the issuer—5,478$111.4069,042
2023-03-10Disposition to the issuer—5,724$111.4063,318
2023-03-10Disposition to the issuer—5,643$111.4057,675
2023-03-08Grant or award—18,776$0.0074,520

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

DEXCOM’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Kevin SayerChairperson, President & Chief Executive Officer$11,985,324
Jacob LeachEVP, Chief Technology Officer$5,708,273
Chad PattersonEVP, Global Marketing$4,875,133
Paul Flynn · this pageEVP, Global Revenue$4,866,159
Jereme SylvainEVP, Chief Financial Officer$4,738,880
Quentin BlackfordFormer Chief Operating Officer and Former Chief Financial Officer$4,621,854

The full DEXCOM compensation record

free company brief

This page is one person within DEXCOM's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the DEXCOM proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are DEXCOM's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Paul Flynn's compensation dossier · One-time report. No refunds.